Your browser doesn't support javascript.
loading
VERSATILITY OF POLY-4-HYDROXYBUTYRATE (PHASIX™) MESH IN ABDOMINAL WALL SURGERY.
Lima, Diego L; Estrada, Arturo; Pereira, Xavier; Alcabes, Analena; Sreeramoju, Prashanth; Malcher, Flavio.
Afiliación
  • Lima DL; Department of Surgery, Montefiore Medical Center, The Bronx , New York, United States.
  • Estrada A; Department of Surgery, Montefiore Medical Center, The Bronx , New York, United States.
  • Pereira X; Department of Surgery, Montefiore Medical Center, The Bronx , New York, United States.
  • Alcabes A; Department of Surgery, Montefiore Medical Center, The Bronx , New York, United States.
  • Sreeramoju P; Department of Surgery, Montefiore Medical Center, The Bronx , New York, United States.
  • Malcher F; Division of General Surgery, NYU Langone Health, New York, United States.
Arq Gastroenterol ; 59(2): 226-230, 2022.
Article en En | MEDLINE | ID: mdl-35830033
ABSTRACT

BACKGROUND:

Poly-4-hydroxybutyrate (P4HB) is a naturally occurring polymer derived from transgenic E. coli bacteria with the longest degradation rate when compared to other available products. This polymer has been manufactured as a biosynthetic mesh to be used as reinforcement when repairing a variety of abdominal wall defects.

OBJECTIVE:

We aim to describe our center initial experience with this mesh and discuss the possible indications that may benefit from the use of P4HB mesh.

METHODS:

This is a descriptive retrospective study of patients who underwent abdominal wall repair with a P4HB mesh from October 2018 to December 2020 in a single, large volume, academic center.

RESULTS:

A total of 51 patients (mean age 54.4 years, range 12-89) underwent abdominal wall reconstruction with a P4HB mesh between October 2018 and December 2020. The mean BMI was 30.5 (range 17.2-50.6). Twenty-three (45%) patients had a prior hernia repair at the site. We grouped patients into six different indications for the use of P4HB mesh in our cohort clean-contaminated, contaminated or infected field (57%), patient refusal for permanent meshes (14%), those with high risk for post-operative infection (12%), visceral protection of second mesh (10%), recurrence with related chronic pain from mesh (6%), and children (2%). Median follow-up was 105 days (range 8-648). Two patients had hernia recurrence (4%) and 8 (16%) patients developed seroma.

CONCLUSION:

P4HB mesh is a safe and a viable alternative for complex hernias and high-risk patients with a low complication rate in the short-term.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pared Abdominal / Hernia Ventral Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Arq Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pared Abdominal / Hernia Ventral Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Humans / Middle aged Idioma: En Revista: Arq Gastroenterol Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos